JP2006505543A5 - - Google Patents

Download PDF

Info

Publication number
JP2006505543A5
JP2006505543A5 JP2004541500A JP2004541500A JP2006505543A5 JP 2006505543 A5 JP2006505543 A5 JP 2006505543A5 JP 2004541500 A JP2004541500 A JP 2004541500A JP 2004541500 A JP2004541500 A JP 2004541500A JP 2006505543 A5 JP2006505543 A5 JP 2006505543A5
Authority
JP
Japan
Prior art keywords
alkyl
optionally substituted
halogen
disubstituted
acyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004541500A
Other languages
English (en)
Japanese (ja)
Other versions
JP4413781B2 (ja
JP2006505543A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/027433 external-priority patent/WO2004030611A2/en
Publication of JP2006505543A publication Critical patent/JP2006505543A/ja
Publication of JP2006505543A5 publication Critical patent/JP2006505543A5/ja
Application granted granted Critical
Publication of JP4413781B2 publication Critical patent/JP4413781B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004541500A 2002-08-23 2003-08-22 非ヌクレオシド逆転写酵素インヒビター Expired - Fee Related JP4413781B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US0226816 2002-08-23
PCT/US2003/027433 WO2004030611A2 (en) 2002-08-23 2003-08-22 Non-nucleoside reverse transcriptase inhibitors

Publications (3)

Publication Number Publication Date
JP2006505543A JP2006505543A (ja) 2006-02-16
JP2006505543A5 true JP2006505543A5 (enExample) 2006-04-06
JP4413781B2 JP4413781B2 (ja) 2010-02-10

Family

ID=32067653

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004541500A Expired - Fee Related JP4413781B2 (ja) 2002-08-23 2003-08-22 非ヌクレオシド逆転写酵素インヒビター

Country Status (13)

Country Link
US (2) US20060135556A1 (enExample)
EP (2) EP1545483B1 (enExample)
JP (1) JP4413781B2 (enExample)
CN (1) CN1697650B (enExample)
AT (1) ATE504294T1 (enExample)
AU (2) AU2003295324B2 (enExample)
BR (1) BR0313747A (enExample)
CA (1) CA2496565C (enExample)
DE (1) DE60336664D1 (enExample)
EA (1) EA009478B1 (enExample)
MX (1) MXPA05002070A (enExample)
WO (1) WO2004030611A2 (enExample)
ZA (1) ZA200502384B (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2496565C (en) * 2002-08-23 2013-04-02 Ribapharm Inc. Non-nucleoside reverse transcriptase inhibitors
US7642277B2 (en) * 2002-12-04 2010-01-05 Boehringer Ingelheim International Gmbh Non-nucleoside reverse transcriptase inhibitors
GB0315111D0 (en) 2003-06-27 2003-07-30 Cancer Rec Tech Ltd Substituted 5-membered ring compounds and their use
CA2558224A1 (en) * 2004-03-08 2005-09-22 Wyeth Ion channel modulators
WO2005090320A2 (en) * 2004-03-12 2005-09-29 Wyeth Triazole derivatives and method of using the same to treat hiv infections
WO2005115147A2 (en) * 2004-05-18 2005-12-08 Merck & Co., Inc. Hiv reverse transcriptase inhibitors
US7517998B2 (en) * 2004-06-01 2009-04-14 Boehringer Ingelheim International Gmbh Non nucleoside reverse transcriptase inhibitors
KR101241716B1 (ko) * 2004-08-25 2013-03-08 아디아 바이오사이언스즈 인크. HIV 역 전사 효소의 억제제로서 S-트리아졸릴 α-메르캅토아세트아닐리드
WO2007050087A1 (en) * 2004-08-25 2007-05-03 Ardea Biosciences, Inc. N[S(4-aryl-triazol-3-yl)α -mercaptoacetyl]-p-amino benozoic acids AS HIV REVERSE TRANSCRIPTASE INHIBITORS
BRPI0714880A2 (pt) * 2006-07-24 2013-05-21 Gilead Sciences Inc inibidores da transcriptase reversa do hiv
WO2009030996A1 (en) * 2007-09-05 2009-03-12 Coley Pharmaceutical Group, Inc. Triazole compounds as toll-like receptor (tlr) agonists
DK2217577T3 (da) 2007-11-27 2014-10-20 Ardea Biosciences Inc Hidtil ukendte forbindelser og præparater og fremgangsmåder til anvendelse deraf
US8173690B2 (en) 2008-09-04 2012-05-08 Ardea Biosciences, Inc. Compounds, compositions and methods of using same for modulating uric acid levels
US8242154B2 (en) 2008-09-04 2012-08-14 Ardea Biosciences, Inc. Compounds, compositions and methods of using same for modulating uric acid levels
EP2328874A4 (en) * 2008-09-04 2012-05-09 Ardea Biosciences Inc COMPOSITES, COMPOSITIONS AND METHOD FOR THEIR USE FOR MODULING THE HARNIC ACID MIRROR
US8372807B2 (en) 2009-05-20 2013-02-12 Ardea Biosciences, Inc. Methods of modulating uric acid levels
US9101635B2 (en) 2009-07-10 2015-08-11 Microbiotix, Inc. Inhibitors of filovirus entry into host cells
AP2013006706A0 (en) * 2010-07-02 2013-02-28 Gilead Sciences Inc Napht-2-ylacetic acid derivatives to treat AIDS
CN101899013B (zh) * 2010-07-12 2012-07-25 山东大学 2-(2-取代芳基-2h-1,2,4-三唑-3-巯基)乙酰胺衍生物及其制备方法与应用
US9332757B2 (en) 2010-10-25 2016-05-10 Vanderbilt University Composition for inhibition of insect host sensing
AU2012254032B2 (en) * 2011-05-06 2017-02-23 Vanderbilt University Compositions for inhibition of insect sensing
ITMI20120786A1 (it) * 2012-05-09 2013-11-10 Fond Italiana Sclerosi M Ultipla Fism Onlu Modulatori del recettore gpr17
AR091651A1 (es) 2012-07-03 2015-02-18 Ardea Biosciences Inc Elaboracion de acido 2-(5-bromo-4-(4-ciclopropilnaftalen-1-il)-4h-1,2,4-triazol-3-iltio)acetico
RU2626003C2 (ru) * 2014-04-28 2017-07-21 Общество с ограниченной ответственностью "Квантум Фармасьютикалс" Амид 1,2,4-триазол-3-илтиогликолевой кислоты, обладающий противовирусной активностью, или его фармацевтически приемлемые соли, фармацевтические композиции и их применение для лечения и профилактики гриппа
US10791739B2 (en) 2015-03-25 2020-10-06 Vanderbilt University Binary compositions as disruptors of orco-mediated odorant sensing
CA2985542C (en) 2015-05-20 2023-10-10 Amgen Inc. Triazole agonists of the apj receptor
WO2017192485A1 (en) 2016-05-03 2017-11-09 Amgen Inc. Heterocyclic triazole compounds as agonists of the apj receptor
EP3541805B1 (en) 2016-11-16 2020-10-14 Amgen Inc. Heteroaryl-substituted triazoles as apj receptor agonists
WO2018097944A1 (en) 2016-11-16 2018-05-31 Amgen Inc. Triazole furan compounds as agonists of the apj receptor
US10689367B2 (en) 2016-11-16 2020-06-23 Amgen Inc. Triazole pyridyl compounds as agonists of the APJ receptor
US11191762B2 (en) 2016-11-16 2021-12-07 Amgen Inc. Alkyl substituted triazole compounds as agonists of the APJ Receptor
WO2018093579A1 (en) 2016-11-16 2018-05-24 Amgen Inc. Triazole phenyl compounds as agonists of the apj receptor
US11020395B2 (en) 2016-11-16 2021-06-01 Amgen Inc. Cycloalkyl substituted triazole compounds as agonists of the APJ receptor
MA50509A (fr) 2017-11-03 2021-06-02 Amgen Inc Agonistes de triazole fusionnés du récepteur apj
MA52487A (fr) 2018-05-01 2021-03-10 Amgen Inc Pyrimidinones substituées en tant qu'agonistes du récepteur apj

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0759563B2 (ja) * 1987-01-28 1995-06-28 大塚化学株式会社 ピラゾ−ル誘導体、その製造方法及び該誘導体を有効成分とする除草剤
EP0303301A3 (en) * 1987-08-14 1989-05-17 Fuji Photo Film Co., Ltd. Silver halide photographic material
US6832996B2 (en) * 1995-06-07 2004-12-21 Arthrocare Corporation Electrosurgical systems and methods for treating tissue
US6245817B1 (en) * 1997-02-14 2001-06-12 Bayer Corporation NPY5 receptor antagonists and methods for using same
WO1998035957A1 (en) * 1997-02-14 1998-08-20 Bayer Corporation Amide derivatives as selective neuropeptide y receptor antagonists
BRPI9909191B8 (pt) * 1998-03-27 2021-07-06 Janssen Pharmaceutica Nv derivados de pirimidina inibidores do hiv, seu uso e composição farmacêutica que os compreende
US6414147B1 (en) * 1998-12-23 2002-07-02 Neurogen Corporation 2-amino-9-alkylpurines: GABA brain receptor ligands
US6593077B2 (en) * 1999-03-22 2003-07-15 Special Materials Research And Technology, Inc. Method of making thin films dielectrics using a process for room temperature wet chemical growth of SiO based oxides on a substrate
CA2439820A1 (en) 2001-03-02 2002-09-12 Smithkline Beecham Corporation Benzophenones as inhibitors of reverse transcriptase
CA2496565C (en) * 2002-08-23 2013-04-02 Ribapharm Inc. Non-nucleoside reverse transcriptase inhibitors
US7642277B2 (en) * 2002-12-04 2010-01-05 Boehringer Ingelheim International Gmbh Non-nucleoside reverse transcriptase inhibitors
US20060205026A1 (en) * 2002-12-19 2006-09-14 Valeant Research & Development Parallel inducible cell-based kinase screen
WO2007050087A1 (en) * 2004-08-25 2007-05-03 Ardea Biosciences, Inc. N[S(4-aryl-triazol-3-yl)α -mercaptoacetyl]-p-amino benozoic acids AS HIV REVERSE TRANSCRIPTASE INHIBITORS
US7897624B2 (en) * 2006-04-18 2011-03-01 Ardea Biosciences Pyridone sulfonamides and pyridone sulfamides as MEK inhibitors
US8101799B2 (en) * 2005-07-21 2012-01-24 Ardea Biosciences Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK
US7842836B2 (en) * 2006-04-11 2010-11-30 Ardea Biosciences N-aryl-N'alkyl sulfamides as MEK inhibitors
EP2132211A4 (en) * 2006-11-09 2011-12-07 Ardea Biosciences Inc 4-CYANPHENYLAMINO-SUBSTITUTED BICYCLIC AND HETEROCYCLIC COMPOUNDS AS AN HIV HEMMER

Similar Documents

Publication Publication Date Title
JP2006505543A5 (enExample)
JP2008510828A5 (enExample)
JP2008535902A5 (enExample)
JP2008535903A5 (enExample)
JP2005523922A5 (enExample)
JP2010511721A5 (enExample)
JP2010504346A5 (enExample)
JP2009504764A5 (enExample)
JP2007537147A5 (enExample)
JP2020517707A5 (enExample)
JP2008526999A5 (enExample)
JP2009504763A5 (enExample)
JP2011529918A5 (enExample)
JP2009519243A5 (enExample)
JP2010501478A5 (enExample)
JP2006524660A5 (enExample)
JPWO2019155399A5 (enExample)
JP2005511699A5 (enExample)
JP2011509309A5 (enExample)
RU2020102453A (ru) Фармацевтические композиции
JP2013514980A5 (enExample)
JP2011529502A5 (enExample)
JP2012508249A5 (enExample)
JP2009520695A5 (enExample)
RU2011133128A (ru) Противоопухолевые соединения дигидропиран-2-она